• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统循证评价:应用游离胎儿 DNA 进行一般风险孕妇的产前筛查。

Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, School of Medicine, University of Utah, Salt Lake City, UT.

Department of Pathology, VCU School of Medicine, Virginia Commonwealth University, Richmond, VA.

出版信息

Genet Med. 2022 Jul;24(7):1379-1391. doi: 10.1016/j.gim.2022.03.019. Epub 2022 May 24.

DOI:10.1016/j.gim.2022.03.019
PMID:35608568
Abstract

PURPOSE

Noninvasive prenatal screening (NIPS) using cell-free DNA has been assimilated into prenatal care. Prior studies examined clinical validity and technical performance in high-risk populations. This systematic evidence review evaluates NIPS performance in a general-risk population.

METHODS

Medline (PubMed) and Embase were used to identify studies examining detection of Down syndrome (T21), trisomy 18 (T18), trisomy 13 (T13), sex chromosome aneuploidies, rare autosomal trisomies, copy number variants, and maternal conditions, as well as studies assessing the psychological impact of NIPS and the rate of subsequent diagnostic testing. Random-effects meta-analyses were used to calculate pooled estimates of NIPS performance (P < .05). Heterogeneity was investigated through subgroup analyses. Risk of bias was assessed.

RESULTS

A total of 87 studies met inclusion criteria. Diagnostic odds ratios were significant (P < .0001) for T21, T18, and T13 for singleton and twin pregnancies. NIPS was accurate (≥99.78%) in detecting sex chromosome aneuploidies. Performance for rare autosomal trisomies and copy number variants was variable. Use of NIPS reduced diagnostic tests by 31% to 79%. Conclusions regarding psychosocial outcomes could not be drawn owing to lack of data. Identification of maternal conditions was rare.

CONCLUSION

NIPS is a highly accurate screening method for T21, T18, and T13 in both singleton and twin pregnancies.

摘要

目的

游离 DNA 的非侵入性产前筛查(NIPS)已被纳入产前护理。先前的研究检查了高危人群的临床有效性和技术性能。本系统证据综述评估了 NIPS 在一般风险人群中的表现。

方法

使用 Medline(PubMed)和 Embase 来确定研究检测唐氏综合征(T21)、18 三体综合征(T18)、13 三体综合征(T13)、性染色体非整倍体、罕见常染色体三体、拷贝数变异和母体状况的研究,以及评估 NIPS 的心理影响和随后诊断性检测率的研究。使用随机效应荟萃分析计算 NIPS 性能的汇总估计值(P<.05)。通过亚组分析研究异质性。评估偏倚风险。

结果

共有 87 项研究符合纳入标准。对于单胎和双胎妊娠,T21、T18 和 T13 的诊断优势比均具有统计学意义(P<.0001)。NIPS 检测性染色体非整倍体的准确率(≥99.78%)。罕见常染色体三体和拷贝数变异的性能存在差异。NIPS 的使用将诊断性检测减少了 31%至 79%。由于缺乏数据,无法得出关于社会心理结果的结论。母体疾病的识别很少见。

结论

NIPS 是一种在单胎和双胎妊娠中对 T21、T18 和 T13 具有高度准确性的筛查方法。

相似文献

1
Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies.系统循证评价:应用游离胎儿 DNA 进行一般风险孕妇的产前筛查。
Genet Med. 2022 Jul;24(7):1379-1391. doi: 10.1016/j.gim.2022.03.019. Epub 2022 May 24.
2
The predictive value of prenatal cell-free DNA testing for rare autosomal trisomies: a systematic review and meta-analysis.产前游离胎儿 DNA 检测对罕见常染色体三体的预测价值:系统评价和荟萃分析。
Am J Obstet Gynecol. 2023 Mar;228(3):292-305.e6. doi: 10.1016/j.ajog.2022.08.034. Epub 2022 Aug 24.
3
Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.基于游离细胞 DNA 测序的无创性产前检测的性能:36456 例单胎和多胎妊娠的经验。
BMC Med Genomics. 2021 Mar 30;14(1):93. doi: 10.1186/s12920-021-00941-y.
4
Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.基于非下一代测序的无创性产前检测技术的评估及临床应用。
Curr Issues Mol Biol. 2021 Aug 17;43(2):958-964. doi: 10.3390/cimb43020068.
5
[Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].母体外周血游离胎儿DNA产前检测的回顾性分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023 Aug 10;40(8):933-938. doi: 10.3760/cma.j.cn511374-20220815-00545.
6
Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.游离胎儿 DNA 检测在母体外周血中用于唐氏综合征 21、18 和 13 三体产前检测的成本效益:系统评价。
Eur J Health Econ. 2018 Sep;19(7):979-991. doi: 10.1007/s10198-017-0946-y. Epub 2017 Dec 16.
7
Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.基于基因组学的非侵入性产前检测用于检测孕妇胎儿染色体非整倍体。
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD011767. doi: 10.1002/14651858.CD011767.pub2.
8
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.在中国一个试点城市,非侵入性产前检测在 21 三体、18 三体、13 三体和性染色体非整倍体的一线筛查中表现出良好的临床性能。
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
9
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
10
Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.基于大型转诊基因诊断实验室数据的无细胞非侵入性产前筛查的阳性预测值估计
Am J Obstet Gynecol. 2017 Dec;217(6):691.e1-691.e6. doi: 10.1016/j.ajog.2017.10.005. Epub 2017 Oct 13.

引用本文的文献

1
Clinical experience of genome-wide non-invasive prenatal testing as a first-tier screening test in a cohort of 59,771 pregnancies.在59771例妊娠队列中,全基因组无创产前检测作为一线筛查试验的临床经验。
PLoS One. 2025 Aug 18;20(8):e0329463. doi: 10.1371/journal.pone.0329463. eCollection 2025.
2
Counseling prior to cfDNA screening: are we giving the right numbers?cfDNA筛查前的咨询:我们提供的数字正确吗?
Arch Gynecol Obstet. 2025 Jul 10. doi: 10.1007/s00404-025-08108-1.
3
Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome.
确定基因组畸变的起源可提高无创产前检测对22q11.2缺失综合征的阳性预测值。
Sci Rep. 2025 Jul 9;15(1):24755. doi: 10.1038/s41598-025-10446-8.
4
Application of non-invasive prenatal testing for fetal chromosomal disorders in low-risk pregnancies: a follow-up study in central China.低风险妊娠中胎儿染色体疾病无创产前检测的应用:中国中部地区的一项随访研究。
Front Genet. 2025 Jun 18;16:1574775. doi: 10.3389/fgene.2025.1574775. eCollection 2025.
5
Diagnostic potential of cell-free fetal nucleic acids in predicting pregnancy complications: A systematic review and meta-analysis on trisomy, pre-eclampsia, and gestational diabetes.游离胎儿核酸在预测妊娠并发症中的诊断潜力:关于三体综合征、子痫前期和妊娠期糖尿病的系统评价与荟萃分析
Int J Reprod Biomed. 2025 May 1;23(2):111-130. doi: 10.18502/ijrm.v23i2.18476. eCollection 2024 May.
6
The Art (and Science) of Individualized Selection of Non-Invasive Prenatal Screening (NIPS).非侵入性产前筛查(NIPS)个体化选择的艺术(与科学)
Int J Womens Health. 2025 May 7;17:1271-1283. doi: 10.2147/IJWH.S437214. eCollection 2025.
7
NIPT of Maternal Plasma-Originated cfDNA: Applications and Guide for the Implementation.母血来源游离DNA的无创产前检测:应用与实施指南
Appl Clin Genet. 2025 Apr 26;18:41-53. doi: 10.2147/TACG.S451444. eCollection 2025.
8
Second trimester soft markers: still worth to be mentioned?孕中期软指标:仍值得一提吗?
Arch Gynecol Obstet. 2025 May;311(5):1233-1240. doi: 10.1007/s00404-025-08021-7. Epub 2025 Apr 9.
9
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism.从液体活检中吸取的经验教训:癌症及妊娠获得性微嵌合体中循环细胞和游离DNA的评估
Semin Immunopathol. 2025 Feb 1;47(1):14. doi: 10.1007/s00281-025-01042-z.
10
Expanded non-invasive prenatal testing offers better detection of fetal copy number variations but not chromosomal aneuploidies.扩展的无创产前检测能更好地检测胎儿拷贝数变异,但不能检测染色体非整倍体。
PLoS One. 2025 Jan 24;20(1):e0312184. doi: 10.1371/journal.pone.0312184. eCollection 2025.